BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

Michael Brinkman

Session 3 – Growth with Exit Strategy

Date:21 July (Wednesday)
Time:  14:00 – 15:30 (GMT+8)

Michael Brinkman

Managing Director and Head of Biopharmaceuticals Investment Banking
Jefferies LLC

 

Michael Brinkman is a Managing Director in the Global Healthcare Investment Banking Group at Jefferies. He focuses on U.S. Biotechnology and Specialty Pharmaceutical companies. Mr. Brinkman has been one of the most active investment bankers to small and mid-cap Biotechnology companies during his 26-year investment banking career. Prior to joining Jefferies, he was a Managing Director at Piper Jaffray for two years, and head of biotechnology investment banking at CIBC World Markets where he spent 14 years. Before that, Mr. Brinkman worked as an actuary in life and health insurance companies in the U.S. and South Africa. He graduated magna cum laude with a BS degree from the University of the Witwatersrand in South Africa and his Fellowship from the Faculty of Actuaries in Edinburgh, Scotland.
.

 

.